Literature DB >> 4036955

Enzyme activities of cultured erythroblasts.

K Shinohara, K Yamada, M Inoue, Y Yoshizaki, Y Ishida, T Kaneko, N Matsumoto.   

Abstract

The enzyme activities of cultured early erythroid progenitor cells (burst-forming unit erythroid, BFU-E) were measured and were compared with the activities of mature erythrocytes. The enzyme activity of acetylcholinesterase was not detectable in the erythroblasts. The ratios of phosphofructokinase and glutathione peroxidase were low due to low enzyme activities in both the erythroblasts and erythrocytes. The ratios of triose phosphate isomerase, phosphoglycerate kinase, and adenylate kinase were low due to high enzyme activities in both the erythroblasts and erythrocytes. The ratios of hexokinase, glucose phosphate isomerase, monophosphoglyceromutase, pyruvate kinase, and adenosine deaminase were high due to high enzyme activities in the erythroblasts. The isozyme of erythroblast hexokinase was of the prototype isozyme I, while pyruvate kinase was predominantly of the prototype M2, with two hybrid isozymes to the anodal side by electrophoresis. These facts suggest that there is a greatly different metabolic pattern during the maturation of the erythroid cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4036955     DOI: 10.1002/ajh.2830200207

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  2 in total

1.  Variations of glycolytic kinases and pentose-phosphate pathway dehydrogenases in response to lead accumulation in hemopoietic cells of rock doves (Columba livia).

Authors:  M Gonzalez; M C Tejedor
Journal:  Bull Environ Contam Toxicol       Date:  1993-05       Impact factor: 2.151

2.  First mutation in the red blood cell-specific promoter of hexokinase combined with a novel missense mutation causes hexokinase deficiency and mild chronic hemolysis.

Authors:  Karen M K de Vooght; Wouter W van Solinge; Annet C van Wesel; Sabina Kersting; Richard van Wijk
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.